Exane Derivatives’s SciPlay Corporation Class A Common Stock SCPL Stock Holding History

Exane Derivatives’s Portfolio SCPL Stock Details SCPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.57K	Sell	184 -886	-83%	-$11.8K	﹤0.01%	422
2022 Q1	$13.8K	Hold	1,070	–	–	﹤0.01%	672
2021 Q4	$14.7K	Hold	1,070	–	–	﹤0.01%	583
2021 Q3	$22.1K	Sell	1,070 -750	-41%	-$13.2K	0.01%	676
2021 Q2	$29K	Hold	1,820	–	–	0.01%	684
2021 Q1	$29.4K	Buy	+1,820	New	+$31.4K	0.01%	547

Other funds holding SCPL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

CIA

Caledonia Investments (Australia) Sydney NSW, Australia $2.93B AUM 37.21% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Exane Derivatives's SCPL Position: Q2 2022 in Review

Exane Derivatives reduced its SciPlay Corporation Class A Common Stock (SCPL) stake by 83% in Q2 2022, selling an estimated $11.8K and leaving 184 shares worth $2.57K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

Exane Derivatives first reported a position in SCPL in Q1 2021 and has held it in 6 quarters since. The position peaked at $29.4K in Q1 2021. 102 funds tracked by Wall St. Rank hold SCPL as of Q2 2022.

Exane Derivatives held 184 shares of SciPlay Corporation Class A Common Stock worth $2.57K as of Q2 2022.
Exane Derivatives sold 886 SciPlay Corporation Class A Common Stock shares in Q2 2022, an estimated $11.8K.
SciPlay Corporation Class A Common Stock made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #422 holding.
Exane Derivatives first reported a position in SciPlay Corporation Class A Common Stock in Q1 2021 and has held it in 6 quarters since.
Exane Derivatives's SciPlay Corporation Class A Common Stock position peaked at $29.4K in Q1 2021.
102 funds tracked by Wall St. Rank held SciPlay Corporation Class A Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.